{
    "other_tests": [
        {
            "procedure_name": "Exploratory laparotomy with drainage of ascites",
            "date": "Not specified",
            "findings": "Optimal cytoreductive surgery with less than 1 cm of peritoneal disease remaining; pathologic findings consistent with epithelial ovarian cancer of mixed endometrioid/clear cell histology; metastatic adenocarcinoma noted in the left paracolic gutter.",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "Total abdominal hysterectomy",
            "date": "Not specified",
            "findings": "Had cancer, uterus and fallopian tubes free of disease.",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "Bilateral salpingo-oophorectomy",
            "date": "Not specified",
            "findings": "Part of the surgical management for ovarian cancer.",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "Infracolic omentectomy",
            "date": "Not specified",
            "findings": "Part of the surgical management for ovarian cancer.",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "Clinical Trial Participation",
            "date": "Not specified",
            "findings": "Participated in a clinical trial of maintenance abagovomab vs placebo, which did not show a PFS or overall survival benefit over placebo.",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "CA125 monitoring",
            "date": "Not specified",
            "findings": "CA125 normalized after first cycle of chemotherapy with a nadir of 110 U/mL; CA125 considered part of routine follow-up.",
            "changes_over_time": "Indicated rapid normalization with chemotherapy."
        }
    ]
}